Gatti M, Pinato S, Maiolica A, Rocchio F, Prato MG, Aebersold R and Penengo L: RNF168 promotes non-canonical K27 ubiquitination to signal DNA damage. Cell Reports (2015), DOI: 10.1016/j.celrep.2014.12.021.

Maiolica A, De Medina Redondo M, Villa F, Schoof E, Jeganatgan S, Gatti M, Gillet L, Herzog F, Novy K, Musacchio A, Meraldi P, Penengo L, Turk B, Linding R, Aebersold R. Modulation of the chromatin phosphoproteome by the Haspin protein kinase. Mol & Cell Proteomics (2014), 7: 1724-40.

Gatti M, Pinato S, Maspero E, Soffientini P, Polo S and Penengo L: A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by RNF168 ubiquitin ligase. Cell Cycle (2012),11, 2538-2544.

Pinato S, Gatti M, Scandiuzzi C, Confalonieri S and Penengo L: UMI, a novel RNF168 ubiquitin binding domain involved in the DNA damage signaling pathway. Mol Cell Biol (2011), 31: 118-26.

Pinato S, Scandiuzzi C, Arnaudo N, Citterio E, Gaudino G and Penengo L: RNF168, a new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of histones H2A and H2AX. BMC Mol Biol (2009), 10:55.

Woelk T, Sigismund S, Penengo L, Polo S: The ubiquitination code: a signalling problem. Cell Div (2007), 2:11.

Penengo L, Mapelli M, Murachelli AG, Confalonieri S, Magri L, Musacchio A, Di Fiore PP, Polo S, Schneider TR: Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. Cell (2006), 124(6):1183-1195.

Germano S, Barberis D, Santoro MM, Penengo L, Citri A, Yarden Y, Gaudino G: Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling. J Biol Chem 2006, 281(31):21710-21719.

Penengo L, Rubin C, Yarden Y, Gaudino G: c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene (2003), 22(24):3669-3679.

Brunelleschi S, Penengo L, Santoro MM, Gaudino G: Receptor tyrosine kinases as target for anti-cancer therapy. Curr Pharm Des (2002), 8(22):1959-1972.

Cacciotti P, Libener R, Betta P, Martini F, Porta C, Procopio A, Strizzi L, Penengo L, Tognon M, Mutti L et al: SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A (2001), 98(21):12032-12037.

Brunelleschi S, Penengo L, Lavagno L, Santoro C, Colangelo D, Viano I, Gaudino G: Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Br J Pharmacol (2001), 134(6):1285-1295.

Santoro MM, Penengo L, Orecchia S, Cilli M, Gaudino G: The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site. Oncogene (2000), 19(45):5208-5211.

Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M, Gaudino G: Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor. Oncogene (1998), 17(6):741-749.